USP calls for industry feedback on proposed HPMC monograph

By Gareth Macdonald contact

- Last updated on GMT

USP calls for industry feedback on proposed HPMC monograph

Related tags: Microbiology, Usp

The USP has proposed monograph for hypromellose capsule shells used to make vegetarian friendly medicines.

The monograph – which was published in September in the Pharmacopeial Forum (42-4) – defines the non-animal product derived capsules as consisting of two pieces, a body and a cap, which overlap and maintain a tight closure.

The document also specifies the materials from which hypromellose capsules can be made and how they can be combined with plasticizers, surfactants, gelling agents, dispersing agents, flavoring agents, antimicrobial agents, and sweeteners.

The monograph also specifies the drying, disintegration and microbial resistance tests the capsules must pass and outlines appropriate storage conditions.

The United States Pharmacopoeial Convention (USP) called for industry feedback, extending the original September 30 deadline for comments.

Industry response

Some suppliers have already commented.

A Capsugel spokesman told us “Capsugel is pleased that USP is developing a monograph for HPMC capsules as it helps to provide clarity to the industry. As such, we were happy to provide detailed technical input to USP when requested.”

Related news

Show more

Related products

Transforming Clinical Development

Transforming Clinical Development

PerkinElmer | 01-Jun-2021 | Technical / White Paper

The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...

The Effect of Tamping Force on Bi-Layer Tablets

The Effect of Tamping Force on Bi-Layer Tablets

JRS PHARMA | 15-Aug-2020 | Technical / White Paper

Formulation of bi-layer or multi-layer tablets enables the combination of two or more drugs that may be incompatible or maybe intended for delivery at...

Flow Cytometry Services

Flow Cytometry Services

Q² Solutions | 01-Jun-2020 | Data Sheet

We are an established leader in flow cytometry services for clinical trials. Our technologies and solutions meet the growing global demand for enhanced...

Related suppliers

Follow us


View more